• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mouse model for pre-clinical study of human cancer immunotherapy.用于人类癌症免疫疗法临床前研究的小鼠模型。
Curr Protoc Immunol. 2015 Feb 2;108:20.1.1-20.1.43. doi: 10.1002/0471142735.im2001s108.
2
B16 as a mouse model for human melanoma.B16作为人类黑色素瘤的小鼠模型。
Curr Protoc Immunol. 2001 May;Chapter 20:Unit 20.1. doi: 10.1002/0471142735.im2001s39.
3
Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.使用经基因改造的粒细胞巨噬细胞集落刺激因子树突状细胞产生的混合细胞疫苗对已形成的肿瘤进行治疗。
Immunology. 1999 Aug;97(4):616-25. doi: 10.1046/j.1365-2567.1999.00823.x.
4
Efficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route.树突状细胞疫苗接种对B16黑色素瘤的疗效取决于免疫途径。
PLoS One. 2014 Aug 14;9(8):e105266. doi: 10.1371/journal.pone.0105266. eCollection 2014.
5
Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.用编码小鼠TRP2的重组腺病毒对小鼠进行基于树突状细胞的基因免疫可诱导有效的抗黑色素瘤免疫。
J Gene Med. 1999 Nov-Dec;1(6):400-6. doi: 10.1002/(SICI)1521-2254(199911/12)1:6<400::AID-JGM68>3.0.CO;2-D.
6
Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.在小鼠黑色素瘤中使用抗酪氨酸酶相关蛋白-1单克隆抗体联合DNA疫苗增强肿瘤免疫
Cancer Res. 2008 Dec 1;68(23):9884-91. doi: 10.1158/0008-5472.CAN-08-2233.
7
Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.黑色素瘤的免疫疗法:在疫苗诱导的抗肿瘤免疫与过继性免疫疗法中,干扰素-γ需求的二分法。
J Immunol. 2001 Jun 15;166(12):7370-80. doi: 10.4049/jimmunol.166.12.7370.
8
Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.表达高水平趋化因子基质衍生因子-1/CXCL12的小鼠B16黑色素瘤可诱导肿瘤特异性T细胞化学排斥并逃避免疫控制。
J Immunol. 2006 Mar 1;176(5):2902-14. doi: 10.4049/jimmunol.176.5.2902.
9
Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection.针对黑素细胞谱系特异性抗原gp100的基因疫苗可诱导细胞毒性T淋巴细胞介导的肿瘤保护作用。
Cancer Res. 1998 Jun 15;58(12):2509-14.
10
Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma.I型极化的BRAF脉冲树突状细胞诱导抗原特异性CD8 + T细胞,这些细胞会影响BRAF突变的小鼠黑色素瘤。
Melanoma Res. 2016 Feb;26(1):1-11. doi: 10.1097/CMR.0000000000000203.

引用本文的文献

1
Advances in nanotechnology-enabled adjuvants for peptide-based cancer vaccines.基于肽的癌症疫苗的纳米技术辅助剂研究进展。
Nano Res. 2025 Jul;18(7). doi: 10.26599/nr.2025.94907534. Epub 2025 May 22.
2
A functional comparison of two transplantable syngeneic mouse models of melanoma: B16F0 and YUMM1.7.两种可移植的同基因小鼠黑色素瘤模型的功能比较:B16F0和YUMM1.7。
bioRxiv. 2025 Jun 10:2025.05.09.652938. doi: 10.1101/2025.05.09.652938.
3
Intravital imaging of pulmonary lymphatics in inflammation and metastatic cancer.炎症和转移性癌症中肺淋巴管的活体成像
J Exp Med. 2025 May 5;222(5). doi: 10.1084/jem.20241359. Epub 2025 Feb 19.
4
Intravital imaging of pulmonary lymphatics in inflammation and metastatic cancer.炎症和转移性癌症中肺淋巴管的活体成像
bioRxiv. 2024 Sep 17:2024.09.12.612619. doi: 10.1101/2024.09.12.612619.
5
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer.移植的支持细胞在感染和癌症的临床前模型中发挥免疫调节而非免疫抑制作用。
Cells. 2024 Mar 19;13(6):544. doi: 10.3390/cells13060544.
6
Structural basis for self-discrimination by neoantigen-specific TCRs.新抗原特异性 TCR 自我识别的结构基础。
Nat Commun. 2024 Mar 8;15(1):2140. doi: 10.1038/s41467-024-46367-9.
7
Structural Basis for Self-Discrimination by Neoantigen-Specific TCRs.新抗原特异性TCR进行自我识别的结构基础
Res Sq. 2023 Jan 31:rs.3.rs-2531184. doi: 10.21203/rs.3.rs-2531184/v1.
8
Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response.靶向 CD47/血小板反应蛋白-1 信号轴调节肿瘤微环境中免疫细胞的生物能量学,增强抗肿瘤免疫反应。
J Immunother Cancer. 2022 Nov;10(11). doi: 10.1136/jitc-2022-004712.
9
In Vitro Cell Impedance Assay to Examine Antigen-Specific T-Cell-Mediated Melanoma Cell Killing to Support Cancer Immunotherapy Drug Discovery.体外细胞阻抗测定法检测抗原特异性T细胞介导的黑色素瘤细胞杀伤作用以支持癌症免疫治疗药物研发
Methods Mol Biol. 2022;2413:63-68. doi: 10.1007/978-1-0716-1896-7_8.
10
Synergistic Effects of Exercise Training and Vitamin D Supplementation on Mitochondrial Function of Cardiac Tissue, Antioxidant Capacity, and Tumor Growth in Breast Cancer in Bearing-4T1 Mice.运动训练与补充维生素D对4T1荷瘤小鼠心脏组织线粒体功能、抗氧化能力及乳腺癌肿瘤生长的协同作用
Front Physiol. 2021 Apr 13;12:640237. doi: 10.3389/fphys.2021.640237. eCollection 2021.

本文引用的文献

1
Adoptive cell transfer for patients with metastatic melanoma: the potential and promise of cancer immunotherapy.转移性黑色素瘤患者的过继细胞转移:癌症免疫疗法的潜力和前景。
Cancer Control. 2013 Oct;20(4):289-97. doi: 10.1177/107327481302000406.
2
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.供者来源的 CD19 靶向 T 细胞可导致异基因造血干细胞移植后持续存在的恶性肿瘤消退。
Blood. 2013 Dec 12;122(25):4129-39. doi: 10.1182/blood-2013-08-519413. Epub 2013 Sep 20.
3
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.MicroRNA-155 对于效应性 CD8+ T 细胞应对病毒感染和癌症是必需的。
Immunity. 2013 Apr 18;38(4):742-53. doi: 10.1016/j.immuni.2012.12.006.
4
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.抗 MAGE-A3 TCR 基因治疗后的癌症消退和神经毒性。
J Immunother. 2013 Feb;36(2):133-51. doi: 10.1097/CJI.0b013e3182829903.
5
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.抗 PD-L1 抗体在晚期癌症患者中的安全性和活性。
N Engl J Med. 2012 Jun 28;366(26):2455-65. doi: 10.1056/NEJMoa1200694. Epub 2012 Jun 2.
6
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.抗 PD-1 抗体在癌症中的安全性、活性和免疫相关性。
N Engl J Med. 2012 Jun 28;366(26):2443-54. doi: 10.1056/NEJMoa1200690. Epub 2012 Jun 2.
7
gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.gp100 肽疫苗和白细胞介素-2 治疗晚期黑色素瘤患者。
N Engl J Med. 2011 Jun 2;364(22):2119-27. doi: 10.1056/NEJMoa1012863.
8
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.采用针对 NY-ESO-1 的基因工程化淋巴细胞治疗转移性滑膜细胞肉瘤和黑色素瘤患者的肿瘤消退。
J Clin Oncol. 2011 Mar 1;29(7):917-24. doi: 10.1200/JCO.2010.32.2537. Epub 2011 Jan 31.
9
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.针对癌胚抗原的 T 细胞可以介导转移性结直肠癌的消退,但会引起严重的短暂性结肠炎。
Mol Ther. 2011 Mar;19(3):620-6. doi: 10.1038/mt.2010.272. Epub 2010 Dec 14.
10
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer.一种靶向 HLA-A*0201 限制性表位的 TCR 可识别多种癌症中 MAGE-A 抗原超家族的多个表位。
J Immunol. 2011 Jan 15;186(2):685-96. doi: 10.4049/jimmunol.1001775. Epub 2010 Dec 13.

用于人类癌症免疫疗法临床前研究的小鼠模型。

Mouse model for pre-clinical study of human cancer immunotherapy.

作者信息

Ya Zhiya, Hailemichael Yared, Overwijk Willem, Restifo Nicholas P

机构信息

National Cancer Institute, Surgery Branch, Bethesda, Maryland.

Department of Melanoma Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

出版信息

Curr Protoc Immunol. 2015 Feb 2;108:20.1.1-20.1.43. doi: 10.1002/0471142735.im2001s108.

DOI:10.1002/0471142735.im2001s108
PMID:25640991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4361407/
Abstract

This unit describes protocols for developing tumors in mice, including subcutaneous growth, pulmonary metastases of B16 melanoma, and spontaneous melanoma in B-Raf V600E/PTEN deletion transgenic mouse models. Two immunization methods to prevent B16 tumor growth are described using B16.GM-CSF and recombinant vaccinia virus. A therapeutic approach is also included that uses adoptive transfer of tumor antigen-specific T cells. Methods including CTL induction, isolation, testing, and genetic modification of mouse T cells for adoptive transfer by using retrovirus-expressing genes of interest are provided. Additional sections, including growing B16 melanoma, enumerating pulmonary metastases, tumor imaging technique, and use of recombinant viruses for vaccination, are discussed together with safety concerns.

摘要

本单元描述了在小鼠体内诱导肿瘤的实验方案,包括皮下肿瘤生长、B16黑色素瘤的肺转移以及B-Raf V600E/PTEN缺失转基因小鼠模型中的自发性黑色素瘤。还描述了两种使用B16.GM-CSF和重组痘苗病毒预防B16肿瘤生长的免疫方法。此外,还包括一种使用肿瘤抗原特异性T细胞过继转移的治疗方法。提供了相关方法,包括用于过继转移的小鼠T细胞的CTL诱导、分离、检测以及利用表达感兴趣基因的逆转录病毒进行基因改造。还讨论了其他部分内容,包括培养B16黑色素瘤、计数肺转移灶、肿瘤成像技术以及使用重组病毒进行疫苗接种,并提及了安全问题。